|
|
| 0.95 Data as of 10:40am ET |  +0.0099 / +1.05%Today’s Change | 0.74 Today|||52-Week Range 4.10 | +21.79% Year-to-Date |
| Previous close | 0.94 |
| Today’s open | 0.95 |
| Day’s range | 0.95 - 0.95 |
| Volume | 5,123 |
| Average volume (3 months) | 347,170 |
| Market cap | $35.2M |
| Dividend yield | -- |
| Earnings growth (last year) | -39.67% |
| Earnings growth (this year) | +62.26% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +97.76% |
| P/E ratio | NM |
| Price/Sales | 7.31 |
| Price/Book | 4.24 |
| No competitors data available. |
| Last reporting date | August 7, 2013 |
| EPS forecast (this quarter) | $0.41 |
| Annual revenue (last year) | $94.4M |
| Annual profit (last year) | -$93.4M |
| Net profit margin | -98.98% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Richard M. Brenner |
President J. Weston Rose |
Corporate headquarters Cupertino, California |
.
